生物标记技术市场规模、份额、成长分析、按测试类型、按产品、按分析技术、按研究领域、按应用、按地区 - 行业预测，2025 年至 2032 年

2023 年全球生物标记技术市场规模价值344 亿美元，预计将从2024 年的375.6 亿美元成长至2032 年的759.6 亿美元，预计在预测期内（2025-2032 年）的复合年增长率为1.4 %。

全球生物标记技术市场是医疗保健不可或缺的一部分，利用生物标记来评估正常和疾病过程以及治疗反应。聚合酵素链锁反应、次世代定序和免疫测量等关键技术正在被用于识别对癌症、感染疾病、自体免疫疾病等诊断至关重要的生物标记。此外，生物标记可以促进在开发过程中早期检测药物毒性，支持个人化医疗的努力。市场预期成长的动力在于疾病盛行率的不断上升、研发力度的加强以及早期毒性测试的日益普及。然而，初始发现成本高以及对生物标记技术的认识低等挑战可能会阻碍成长。相反，新兴国家为未来市场扩张提供了重大机会，也为创新生物标记应用提供了广阔的前景。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步

生物标记技术市场规模（按测试类型划分）

• 市场概况
• 固态切片检查
• 液态生物检体

生物标誌物技术市场规模（依产品划分）

• 市场概况
• 生物标誌物的识别、检验和开发研究
  • 耗材
  • 装置
  • 服务
  • 软体
• 常规生物标记检测
  • 耗材
  • 装置
  • 服务
  • 软体

按分析技术分類的生物标记技术市场规模

• 市场概况
• 免疫检测
  • ELISA
  • 西方墨点法
  • 蛋白质微阵列
• PCR
• 成像技术
• 质谱分析
• 下一代种子
• 层析法
• 细胞遗传学
• 其他分析技术

生物标记技术市场规模（依研究领域划分）

• 市场概况
• 基因组学
• 蛋白质体学
• 代谢体学
  • 代谢助焊剂
  • 脂类组学
  • 其他的
• 其他研究领域

生物标记技术市场规模（按应用）

• 市场概况
• 生物标誌物的识别、检验和开发研究
• 常规生物标记检测

生物标记技术市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific Inc.（United States）
• Bio-Rad Laboratories, Inc.（United States）
• Danaher Corporation（United States）
• Waters Corporation（United States）
• Shimadzu Corporation（Japan）
• Siemens Healthineers AG（Germany）
• Illumina, Inc.（United States）
• PerkinElmer, Inc.（United States）
• Abbott Laboratories（United States）
• Roche Holding AG（Switzerland）
• Merck KGaA（Germany）
• Becton, Dickinson and Company（United States）
• GE Healthcare（United States）
• Bruker Corporation（United States）
• Hologic, Inc.（United States）
• Myriad Genetics, Inc.（United States）
• Bio-Techne Corporation（United States）

结论和建议

Global Biomarker Technologies Market size was valued at USD 34.4 billion in 2023 and is poised to grow from USD 37.56 billion in 2024 to USD 75.96 billion by 2032, growing at a CAGR of 9.2% during the forecast period (2025-2032).

The global biomarker technologies market is vital in healthcare, leveraging biological markers to evaluate normal and disease processes as well as treatment responses. Key technologies such as polymerase chain reaction, next-generation sequencing, and immunoassays are employed to identify biomarkers critical for diagnosing conditions like cancer, infectious diseases, and autoimmune disorders. Furthermore, biomarkers facilitate early detection of drug toxicity in development and support personalized medicine initiatives. Anticipated market growth is driven by rising disease prevalence, intensified R&D efforts, and increasing adoption of early toxicity testing. However, challenges including high initial discovery costs and limited awareness of biomarker technologies may impede growth. Conversely, emerging economies present significant opportunities for future market expansion, enhancing the scope for innovative biomarker applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomarker Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biomarker Technologies Market Segmental Analysis

Global Biomarker Technologies Market is segmented by Test Type, Product, Profiling Technology, Research Area, Application and region. Based on Test Type, the market is segmented into Solid Biopsy and Liquid Biopsy. Based on Product, the market is segmented into Biomarker Identification, Validation & Development Research and Routine Biomarker-based tests. Based on Profiling Technology, the market is segmented into Immunoassay, PCR, Imaging Technologies, Mass Spectrometry, NGS, Chromatography, Cytogenetics and Other Profiling Technologies. Based on Research Area, the market is segmented into Genomics, Proteomics, Metabolomics and Other Research Areas. Based on Application, the market is segmented into Biomarker Identification, Validation & Development Research and Routine Biomarker-based tests. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biomarker Technologies Market

Global Biomarker Technologies (GBT) leads the charge in advancing precision medicine through the discovery and validation of innovative biomarkers. Focusing on early disease detection, personalized treatment strategies, and enhanced patient monitoring, GBT develops cutting-edge diagnostics that integrate seamlessly into clinical workflows. Their proprietary technology platforms harness the power of genomics, proteomics, and metabolomics to propel research and development across various therapeutic areas, including oncology, cardiology, and neurodegenerative diseases. By fostering collaborations with academic institutions and pharmaceutical companies, GBT accelerates the translation of scientific discoveries into actionable insights, ultimately elevating the standard of care and improving patient outcomes globally.

Restraints in the Global Biomarker Technologies Market

Global Biomarker Technologies must ensure that its research and development practices adhere strictly to ethical guidelines and regulatory standards concerning patient data privacy and consent. Furthermore, the organization should prioritize diversity and inclusivity within its clinical trials to avoid bias in biomarker validation and enhance the applicability of its findings across different populations. The company must also maintain transparent communication with stakeholders about the limitations and potential risks associated with biomarker applications. Finally, Global Biomarker Technologies is encouraged to seek collaborations that foster innovation while aligning with its mission to improve healthcare outcomes globally.

Market Trends of the Global Biomarker Technologies Market

The Global Biomarker Technologies market is witnessing significant growth, propelled by a surge in personalized medicine initiatives that utilize biomarkers for tailored disease management. Advancements in genomics, proteomics, and molecular diagnostics are enhancing the identification of unique biomarkers, facilitating precise diagnosis and targeted therapeutic strategies. Additionally, there is a strong shift towards non-invasive and minimally invasive testing techniques, particularly liquid biopsies, which enhance patient comfort while improving diagnostic accuracy. This convergence of technology and personalized healthcare is fostering innovation and driving investment in biomarker research and development, positioning the market for robust expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Biomarker Technologies Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Solid Biopsy
• Liquid Biopsy

Global Biomarker Technologies Market Size by Product & CAGR (2025-2032)

• Market Overview
• Biomarker Identification, Validation & Development Research
  • Consumables
  • Instruments
  • Services
  • Software
• Routine Biomarker-based tests
  • Consumables
  • Instruments
  • Services
  • Software

Global Biomarker Technologies Market Size by Profiling Technology & CAGR (2025-2032)

• Market Overview
• Immunoassay
  • ELISA
  • Western Blot
  • Protein Microarray
• PCR
• Imaging Technologies
• Mass Spectrometry
• NGS
• Chromatography
• Cytogenetics
• Other Profiling Technologies

Global Biomarker Technologies Market Size by Research Area & CAGR (2025-2032)

• Market Overview
• Genomics
• Proteomics
• Metabolomics
  • Metabolic Flux
  • Lipidomics
  • Others
• Other Research Areas

Global Biomarker Technologies Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biomarker Identification, Validation & Development Research
• Routine Biomarker-based tests

Global Biomarker Technologies Market Size & CAGR (2025-2032)

• North America (Test Type, Product, Profiling Technology, Research Area, Application)
  • US
  • Canada
• Europe (Test Type, Product, Profiling Technology, Research Area, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Product, Profiling Technology, Research Area, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Product, Profiling Technology, Research Area, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Product, Profiling Technology, Research Area, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations